Company Filing History:
7 out of 290 
1 out of 3,381 
1 out of 1 Years Active: 2013-2022
Title: James J Mulé: Innovator in Cancer Treatment
Introduction
James J Mulé is a prominent inventor based in Odessa, FL (US), known for his significant contributions to cancer treatment through innovative methods. He holds a total of 7 patents, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among his latest patents, Mulé has developed groundbreaking methods for treating breast cancer and urothelial carcinoma. His patent titled "Immune gene signatures in treating breast cancer" focuses on utilizing tumor expression levels of chemokines to enhance treatment efficacy. Additionally, his invention "Immune gene signatures in urothelial carcinoma (UC)" addresses bladder cancer treatment by leveraging mRNA expression levels of chemokines.
Career Highlights
Throughout his career, Mulé has worked with esteemed institutions such as the H. Lee Moffitt Cancer Center and Research Institute, Inc. and the University of Texas System. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Some of his notable coworkers include Domenico Coppola and Timothy J Yeatman, who have played essential roles in his research endeavors. Their collaboration has further enriched the innovative approaches to cancer treatment that Mulé has pioneered.
Conclusion
James J Mulé's contributions to cancer treatment through his patents and collaborations highlight his commitment to improving healthcare outcomes. His innovative methods continue to pave the way for advancements in the fight against cancer.